AU1607397A - Use of 1-(4-(3-trifluoromethylphenyl)-1,2,3, 6-tetrahydropyrid-1YL)-2-(6,7-dimethoxynapht-2-YL) ethane for preparing medicines for the treatment of cerebral and neuronal disorders - Google Patents

Use of 1-(4-(3-trifluoromethylphenyl)-1,2,3, 6-tetrahydropyrid-1YL)-2-(6,7-dimethoxynapht-2-YL) ethane for preparing medicines for the treatment of cerebral and neuronal disorders Download PDF

Info

Publication number
AU1607397A
AU1607397A AU16073/97A AU1607397A AU1607397A AU 1607397 A AU1607397 A AU 1607397A AU 16073/97 A AU16073/97 A AU 16073/97A AU 1607397 A AU1607397 A AU 1607397A AU 1607397 A AU1607397 A AU 1607397A
Authority
AU
Australia
Prior art keywords
treatment
dementia
disorders
cerebral
tetrahydropyrid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16073/97A
Other languages
English (en)
Inventor
Tiziano Croci
Jacqueline Fournier
Umberto Guzzi
Costantino Palmieri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Publication of AU1607397A publication Critical patent/AU1607397A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AU16073/97A 1997-02-03 1997-02-03 Use of 1-(4-(3-trifluoromethylphenyl)-1,2,3, 6-tetrahydropyrid-1YL)-2-(6,7-dimethoxynapht-2-YL) ethane for preparing medicines for the treatment of cerebral and neuronal disorders Abandoned AU1607397A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/FR1997/000202 WO1998033502A1 (fr) 1997-02-03 1997-02-03 Utilisation du 1-[4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyrid-1yl]-2-(6,7-dimethoxynapht-2-yl)ethane pour la preparation de medicaments destines aux traitements de troubles cerebraux et neuronaux

Publications (1)

Publication Number Publication Date
AU1607397A true AU1607397A (en) 1998-08-25

Family

ID=9502506

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16073/97A Abandoned AU1607397A (en) 1997-02-03 1997-02-03 Use of 1-(4-(3-trifluoromethylphenyl)-1,2,3, 6-tetrahydropyrid-1YL)-2-(6,7-dimethoxynapht-2-YL) ethane for preparing medicines for the treatment of cerebral and neuronal disorders

Country Status (11)

Country Link
EP (1) EP0954311A1 (cs)
JP (1) JP2001511141A (cs)
AU (1) AU1607397A (cs)
CA (1) CA2279326A1 (cs)
CZ (1) CZ275399A3 (cs)
EE (1) EE9900332A (cs)
HU (1) HUP0000767A3 (cs)
IL (1) IL130994A0 (cs)
IS (1) IS5117A (cs)
TR (1) TR199901722T2 (cs)
WO (1) WO1998033502A1 (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6272180B1 (en) * 1997-11-21 2001-08-07 Sharp Laboratories Of America, Inc. Compression and decompression of reference frames in a video decoder

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
US5618822A (en) * 1990-05-23 1997-04-08 Sanofi N-substituted trifluoromethylphenyltetrahydropyridines, process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them
FR2662442A1 (fr) * 1990-05-23 1991-11-29 Midy Spa Trifluoromethylphenyltetrahydropyridines n-substituees procede pour leur preparation, intermediaires du procede et compositions pharmaceutiques les contenant.

Also Published As

Publication number Publication date
EP0954311A1 (fr) 1999-11-10
CZ275399A3 (cs) 1999-12-15
IL130994A0 (en) 2001-01-28
CA2279326A1 (fr) 1998-08-06
EE9900332A (et) 2000-02-15
WO1998033502A1 (fr) 1998-08-06
TR199901722T2 (xx) 2000-08-21
HUP0000767A3 (en) 2000-10-30
IS5117A (is) 1999-07-15
JP2001511141A (ja) 2001-08-07
HUP0000767A2 (hu) 2000-09-28

Similar Documents

Publication Publication Date Title
US4837226A (en) Polycyclic amine derivatives useful as cerebrovascular agents
AU1607397A (en) Use of 1-(4-(3-trifluoromethylphenyl)-1,2,3, 6-tetrahydropyrid-1YL)-2-(6,7-dimethoxynapht-2-YL) ethane for preparing medicines for the treatment of cerebral and neuronal disorders
US6034090A (en) 1-Phenylalkyl-1,2,3,6-tetrahydropyridines for treating Alzheimer's disease
DE69707504T2 (de) Diphenylalkyl-tetrahydropyridine, verfahren zu ihren herstellung und diese enthaltende arzneimittel
US7297799B2 (en) Preparation of benzoylalkyl-1,2,3,6-tetrahydropyridines and use thereof
KR20000070704A (ko) 대뇌 및 신경원 질환 치료용 약제의 제조에 사용되는 1-[4-(3-트리플루오로메틸페닐)-1,2,3,6-테트라히드로피리드-1-일]-2-(6,7-디메톡시나프트-2-일)에탄의 용도
MXPA99006885A (es) Hoja de impresion por inyeccion de tinta.
MXPA99005651A (es) Uso de benzoilalquil-1,2,3,6-tetrahidropiridinas
MXPA99005108A (en) 1-phenylalkyl-1,2,3,6-tetrahydropyridines for treating alzheimer's disease
CN1245427A (zh) 1－[4－(3－三氟甲基苯基)－1,2,3,6－四氢吡啶－1－基]－2－(6,7－二甲氧基萘－2－基)乙烷在制备用于治疗大脑和神经元疾病的药物中的应用

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period